Shizuoka, Japan

Morimoto Makoto

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Kabushiki Kaisha. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Morimoto Makoto. Retrieved from https://idiyas.com/inventor/morimoto-makoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Morimoto Makoto: Innovator in Mitomycin Derivatives

Introduction

Morimoto Makoto is a distinguished inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on mitomycin derivatives. His innovative approach has led to advancements that are crucial in medical applications.

Latest Patents

Morimoto holds a patent for mitomycin derivatives, showcasing his expertise in developing compounds that have potential therapeutic benefits. This patent highlights his commitment to enhancing medical treatments and improving patient outcomes. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Morimoto is associated with Kyowa Hakko Kogyo Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His role at the company has allowed him to work on groundbreaking research and development projects. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Morimoto has collaborated with notable colleagues, including Saito Yutaka and Kono Motomichi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Morimoto Makoto's work in mitomycin derivatives exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to influence medical advancements and improve treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…